InChI=1S/C19H24O7/c1- 7- 4- 9(20) 14(23) 17(2) 8(7) 5- 10(21) 19- 6- 25- 18(3) 13(19) 16(24) 26- 15(18) 11(22) 12(17) 19/h4,8- 9,11- 15,20,22- 23H,5- 6H2,1- 3H3/t8- ,9- ,11+,12+,13- ,14+,15- ,17- ,18- ,19+/m0/s1 |
PDGZDUYWUXJXRO-ANPVQLFHSA-N |
[H] [C@@] 12OC(=O) [C@@] 3([H] ) [C@] 1(C) OC[C@] 31C(=O) C[C@@] 3([H] ) C(C) =C[C@H] (O) [C@@H] (O) [C@] 3(C) [C@@] 1([H] ) [C@H] 2O |
|
Samadera indica
(NCBI:txid459147)
|
Found in
stem
(BTO:0001300).
See:
PubMed
|
metabolite
Any intermediate or product resulting from metabolism. The term 'metabolite' subsumes the classes commonly known as primary and secondary metabolites.
|
|
antineoplastic agent
A substance that inhibits or prevents the proliferation of neoplasms.
|
|
View more via ChEBI Ontology
(1R,2S,5R,5aR,7aS,10S,11S,11aS,11bR,14S)- 1,10,11- trihydroxy- 8,11a,14- trimethyl- 7,7a,10,11,11a,11b- hexahydro- 2H- 2,5,5a- (methanetriyloxymethano)naphtho[1,2- d]oxepine- 4,6(1H,5H)- dione
|
6667268
|
Reaxys Registry Number
|
Reaxys
|
23302065
|
PubMed citation
|
Europe PMC
|
8945767
|
PubMed citation
|
Europe PMC
|
|